These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3544227)

  • 21. Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication?
    Gentilini P; Laffi G; La Villa G; Romanelli RG; Blendis LM
    J Hepatol; 1999 Dec; 31(6):1088-97. PubMed ID: 10604585
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatorenal syndrome.
    Bataller R; Ginès P; Guevara M; Arroyo V
    Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.
    Arroyo V; Colmenero J
    J Hepatol; 2003; 38 Suppl 1():S69-89. PubMed ID: 12591187
    [No Abstract]   [Full Text] [Related]  

  • 24. [The hepatorenal system: its relation to the physiopathology of renal water and salt retention in liver cirrhosis].
    López-Novoa JM
    Rev Clin Esp; 1988 Jun; 183(1):1-2. PubMed ID: 3175151
    [No Abstract]   [Full Text] [Related]  

  • 25. [Abdominal pain with ascites. Hepatorenal syndrome].
    Schwietert M
    Praxis (Bern 1994); 1999 May; 88(20):920-2. PubMed ID: 10409894
    [No Abstract]   [Full Text] [Related]  

  • 26. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal insufficiency in liver transplantation].
    Rimola A
    Nefrologia; 2002; 22 Suppl 5():69-71. PubMed ID: 12107922
    [No Abstract]   [Full Text] [Related]  

  • 29. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatorenal disorders: role of the sympathetic nervous system.
    Henriksen JH; Ring-Larsen H
    Semin Liver Dis; 1994 Feb; 14(1):35-43. PubMed ID: 8016660
    [No Abstract]   [Full Text] [Related]  

  • 32. The hepatorenal syndrome.
    Epstein M
    Hosp Pract (Off Ed); 1989 Apr; 24(4):65-76. PubMed ID: 2522459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathophysiology of ascites and functional renal failure in cirrhosis.
    Arroyo V; Bernardi M; Epstein M; Henriksen JH; Schrier RW; Rodés J
    J Hepatol; 1988 Apr; 6(2):239-57. PubMed ID: 3045195
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis.
    Angeli P; Merkel C
    J Hepatol; 2008; 48 Suppl 1():S93-103. PubMed ID: 18304678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liver cirrhosis and cardiovascular system].
    Ponte E; Cafagna D
    Minerva Med; 1996 Jun; 87(6):299-310. PubMed ID: 8700359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New aspects of the physiopathology and treatment of the hepatorenal syndrome].
    Pavão dos Santos OF; Schor N; Higa EM; Sigulem D; Ramos OL
    AMB Rev Assoc Med Bras; 1984; 30(1-2):20-5. PubMed ID: 6377404
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatorenal syndrome].
    Romejko-Ciepielewska K; Niemczyk S
    Pol Arch Med Wewn; 2005 Aug; 114(2):813-8. PubMed ID: 16808322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.